REG - Eco Animal Health Gp - New USA and Canada label claim for Aivlosin®

ECO Animal HealthAnnouncement

24/10/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231024:nRSX0235Ra&default-theme=true

RNS Number : 0235R  Eco Animal Health Group PLC  24 October 2023

 

 

24 October 2023

ECO Animal Health Group plc

(''ECO", the "Company" or the "ECO Group")

(AIM: EAH)

New USA and Canada label claim for Aivlosin®

 

ECO Animal Health Group plc, a leader in the development, registration and
marketing of pharmaceutical products for global animal health markets, is
pleased to announce that it has received a new US and Canadian label claim
indication for Aivlosin® Water Soluble Granules ("WSG") in pigs.

Following years of research into the sow reproductive safety of Aivlosin®
WSG, a new 'sow safety' indication has been approved by the US Food & Drug
Administration (FDA). Prior to this approval, the label indication restricted
WSG to be used only in the drinking water of swine intended for slaughter and
not for use in lactating or pregnant females, or males and females intended
for breeding.

The new label indication will be 'For use only in the drinking water of swine
intended for slaughter and female swine intended for breeding. Not for use in
male swine intended for breeding'.

Meanwhile, the Veterinary Drugs Directorate in Canada has also approved the
removal of label statements regarding 'not for use in lactating or pregnant
females and females intended for breeding'.

David Halls, CEO, commented: "We are pleased to have received this new label
claim approved by the FDA which gives permission for ECO to sell into an
additional market segment. This is testament to the continued market
development of our products and these new claims and labels further enhance
the safety message already used for Aivlosin in pigs."

 

For further information please contact:

 ECO Animal Health Group plc                                     020 8447 8899

 David Hallas (CEO)

 Christopher Wilks (CFO)

 IFC Advisory                                                    020 3934 6630

 Graham Herring

 Zach Cohen

 Singer Capital Markets (Nominated Adviser & Joint Broker)       020 7496 3000

 Phil Davies

 Sam Butcher

 Investec (Joint Broker)                                         020 7597 5970

 Gary Clarence

 Lydia Zychowska

 Carlo Spingardi

 

 Equity Development  020 7065 2692

 Hannah Crowe

 Matt Evans

 

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products
for livestock. Our business strategy is to generate shareholder value by
achieving the maximum sales potential from the existing product portfolio
whilst investing in Research and Development ("R&D") for new products,
particularly vaccines, and seeking to in-license new products.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFLDIRLVFIV